Skip to content

Neomatrix Biotech (Italy)

Request correction

Personalizing cancer immunotherapy with DNA vaccines.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Neomatrix Biotech is a company based in Rome, Italy, focused on personalizing cancer immunotherapy. Its mission is to generate the fastest next generation cancer vaccines to selectively eliminate tumor cells in the body. The company's proprietary platform combines deep knowledge of cancer biology and Immuno-Oncology, cutting-edge technologies to identify patient's tumor neoantigens, innovative design and production of fully-synthetic, personalized DNA vaccines, a potent delivery system to maximize the immune response and the synergic effect with immune checkpoint inhibitors.

History

Neomatrix Biotech is a company in Rome, Italy. Its mission is to generate the fastest next generation cancer vaccines to selectively eliminate tumor cells in the body. The company's proprietary platform combines deep knowledge of cancer biology and Immuno-Oncology, cutting-edge technologies to identify patient's tumor neoantigens, innovative design and production of fully-synthetic, personalized DNA vaccines, a potent delivery system to maximize the immune response and the synergic effect with immune checkpoint inhibitors.

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/neomatrix-biotech-italy · Editorial policy · How profiles are compiled